1
|
Zoeller RT, Birnbaum LS, Collins TJ, Heindel J, Hunt PA, Iguchi T, Kortenkamp A, Myers JP, vom Saal FS, Sonnenschein C, Soto AM. European Medicines Agency Conflicts With the European Food Safety Authority (EFSA) on Bisphenol A Regulation. J Endocr Soc 2023; 7:bvad107. [PMID: 37873497 PMCID: PMC10590640 DOI: 10.1210/jendso/bvad107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Indexed: 10/25/2023] Open
Abstract
The European Food Safety Authority (EFSA) has revised their estimate of the toxicity of bisphenol A (BPA) and, as a result, have recommended reducing the tolerable daily intake (TDI) by 20 000-fold. This would essentially ban the use of BPA in food packaging such as can liners, plastic food containers, and in consumer products. To come to this conclusion, EFSA used a systematic approach according to a pre-established protocol and included all guideline and nonguideline studies in their analysis. They found that Th-17 immune cells increased with very low exposure to BPA and used this endpoint to revise the TDI to be human health protective. A number of regulatory agencies including the European Medicines Agency (EMA) have written formal disagreements with several elements of EFSA's proposal. The European Commission will now decide whether to accept EFSA's recommendation over the objections of EMA. If the Commission accepts EFSA's recommendation, it will be a landmark action using knowledge acquired through independent scientific studies focused on biomarkers of chronic disease to protect human health. The goal of this Perspective is to clearly articulate the monumental nature of this debate and decision and to explain what is at stake. Our perspective is that the weight of evidence clearly supports EFSA's proposal to reduce the TDI by 20 000-fold.
Collapse
Affiliation(s)
- R Thomas Zoeller
- Department of Biology, University of Massachusetts Amherst, Amherst, MA 01003, USA
- School of Science and Technology, University of Örebro, Örebro, Sweden
| | - Linda S Birnbaum
- Scholar in Residence, Nicholas School of the Environment, Duke University, Durham, NC, USA
| | - Terrence J Collins
- Teresa Heinz Professor of Green Chemistry, and Director, Institute for Green Science, Department of Chemistry, Carnegie Mellon University, 4400 Fifth Avenue, Pittsburgh, PA 15213, USA
| | | | - Patricia A Hunt
- School of Molecular Biosciences, Center for Reproductive Biology, Washington State University, Pullman, WA 99164, USA
| | - Taisen Iguchi
- Graduate School of Nanobioscience, Yokohama City University, Yokohama, Kanagawa, 236-0027, Japan
| | - Andreas Kortenkamp
- Centre for Pollution Research and Policy, Brunel University London, Uxbridge UB8 3PH, UK
| | - John Peterson Myers
- Environmental Health Sciences, Charlottesville, VA, USA
- Department of Chemistry, Carnegie, Mellon University, Pittsburgh, PA, USA
| | - Frederick S vom Saal
- Division of Biological Sciences, The University of Missouri, Columbia, MO 65211, USA
| | - Carlos Sonnenschein
- Centre Cavaillès, Ecole Normale Supérieure, Paris, France
- Institut for Advanced Studies, Nantes, France
- Department of Immunology, Tufts University School of Medicine, Boston, USA
| | - Ana M Soto
- Centre Cavaillès, Ecole Normale Supérieure, Paris, France
- Department of Immunology, Tufts University School of Medicine, Boston, USA
| |
Collapse
|
2
|
Barouki R, Melén E, Herceg Z, Beckers J, Chen J, Karagas M, Puga A, Xia Y, Chadwick L, Yan W, Audouze K, Slama R, Heindel J, Grandjean P, Kawamoto T, Nohara K. Epigenetics as a mechanism linking developmental exposures to long-term toxicity. Environ Int 2018; 114:77-86. [PMID: 29499450 PMCID: PMC5899930 DOI: 10.1016/j.envint.2018.02.014] [Citation(s) in RCA: 109] [Impact Index Per Article: 18.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2017] [Revised: 01/13/2018] [Accepted: 02/08/2018] [Indexed: 05/17/2023]
Abstract
A variety of experimental and epidemiological studies lend support to the Developmental Origin of Health and Disease (DOHaD) concept. Yet, the actual mechanisms accounting for mid- and long-term effects of early-life exposures remain unclear. Epigenetic alterations such as changes in DNA methylation, histone modifications and the expression of certain RNAs have been suggested as possible mediators of long-term health effects of environmental stressors. This report captures discussions and conclusions debated during the last Prenatal Programming and Toxicity meeting held in Japan. Its first aim is to propose a number of criteria that are critical to support the primary contribution of epigenetics in DOHaD and intergenerational transmission of environmental stressors effects. The main criteria are the full characterization of the stressors, the actual window of exposure, the target tissue and function, the specificity of the epigenetic changes and the biological plausibility of the linkage between those changes and health outcomes. The second aim is to discuss long-term effects of a number of stressors such as smoking, air pollution and endocrine disruptors in order to identify the arguments supporting the involvement of an epigenetic mechanism. Based on the developed criteria, missing evidence and suggestions for future research will be identified. The third aim is to critically analyze the evidence supporting the involvement of epigenetic mechanisms in intergenerational and transgenerational effects of environmental exposure and to particularly discuss the role of placenta and sperm. While the article is not a systematic review and is not meant to be exhaustive, it critically assesses the contribution of epigenetics in the long-term effects of environmental exposures as well as provides insight for future research.
Collapse
Affiliation(s)
- R Barouki
- INSERM UMR-S 1124, Université Paris Descartes, Paris, France; Service de Biochimie Métabolomique et Protéomique, Hôpital Necker Enfants Malades, AP-HP, Paris, France.
| | - E Melén
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Sachs' Children and Youth Hospital, and Centre for Occupational and Environmental Medicine, Stockholm County Council, Sweden
| | - Z Herceg
- Epigenetics Group, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, F-69008 Lyon, France
| | - J Beckers
- Institute of Experimental Genetics, Helmholtz Zentrum München GmbH, 85764 Neuherberg, Germany; Technische Universität München, Experimental Genetics, 85354 Freising, Germany; German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany
| | - J Chen
- Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - M Karagas
- Department of Epidemiology, Children's Environmental Health and Disease Prevention Research Center at Dartmouth, Hanover, NH, USA
| | - A Puga
- Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, United States
| | - Y Xia
- Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, United States
| | | | - W Yan
- Department of Physiology and Cell Biology, University of Nevada, Reno School of Medicine, 1664 North Virginia Street, Reno, NV 89557, USA MS575; Department of Biology, University of Nevada, Reno, 1664 North Virginia Street, Reno, NV 89557, USA
| | - K Audouze
- INSERM UMR-S973, Molécules Thérapeutiques in silico, University of Paris Diderot, Paris, France
| | - R Slama
- Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France
| | - J Heindel
- Program in Endocrine Disruption Strategies, Commonweal, Bolinas, CA, USA
| | - P Grandjean
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Environmental Medicine, University of Southern Denmark, Odense, Denmark
| | - T Kawamoto
- Department of Environmental Health, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan
| | - K Nohara
- Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba 305-8506, Japan
| |
Collapse
|
4
|
Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, Iguchi T, Juul A, McLachlan JA, Schwartz J, Skakkebaek N, Soto AM, Swan S, Walker C, Woodruff TK, Woodruff TJ, Giudice LC, Guillette LJ. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril 2008; 90:911-40. [PMID: 18929049 DOI: 10.1016/j.fertnstert.2008.08.067] [Citation(s) in RCA: 292] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2008] [Accepted: 08/13/2008] [Indexed: 12/21/2022]
Abstract
OBJECTIVE To evaluate the possible role of endocrine-disrupting compounds (EDCs) on female reproductive disorders emphasizing developmental plasticity and the complexity of endocrine-dependent ontogeny of reproductive organs. Declining conception rates and the high incidence of female reproductive disruptions warrant evaluation of the impact of EDCs on female reproductive health. DESIGN Publications related to the contribution of EDCs to disorders of the ovary (aneuploidy, polycystic ovary syndrome, and altered cyclicity), uterus (endometriosis, uterine fibroids, fetal growth restriction, and pregnancy loss), breast (breast cancer, reduced duration of lactation), and pubertal timing were identified, reviewed, and summarized at a workshop. CONCLUSION(S) The data reviewed illustrate that EDCs contribute to numerous human female reproductive disorders and emphasize the sensitivity of early life-stage exposures. Many research gaps are identified that limit full understanding of the contribution of EDCs to female reproductive problems. Moreover, there is an urgent need to reduce the incidence of these reproductive disorders, which can be addressed by correlative studies on early life exposure and adult reproductive dysfunction together with tools to assess the specific exposures and methods to block their effects. This review of the EDC literature as it relates to female health provides an important platform on which women's health can be improved.
Collapse
|
8
|
Hess D, Keeports R, Didyoung R, Heindel J, Hostetter C. Use of high-frequency jet ventilation to prevent aspiration in a patient with an uncuffed tracheostomy tube. Crit Care Med 1984; 12:918-9. [PMID: 6488836 DOI: 10.1097/00003246-198410000-00019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
We report the use of high-frequency jet ventilation (HFJV) in a patient with an uncuffed tracheostomy tube who had significant pulmonary aspiration of upper-airway secretions. Respiratory secretions decreased during HFJV, indicating that the patient was no longer aspirating. Despite a continuous flow of gas out of the patient's nose and mouth, arterial blood gases remained within acceptable limits. We conclude that HFJV can prevent aspiration and maintain adequate ventilation when used with an uncuffed tracheostomy tube.
Collapse
|